Cachexia in patients with oesophageal cancer (Q38634739)

5 September 2017

Cachexia in patients with oesophageal cancer (English)

1 reference

5 September 2017

Poorna Anandavadivelan

series ordinal

1

1 reference

PubMed ID

26573424

5 September 2017

Pernilla Lagergren

series ordinal

2

1 reference

PubMed ID

26573424

5 September 2017

language of work or name

English

0 references

publication date

17 November 2015

1 reference

Nature Reviews Clinical Oncology

5 September 2017

1 reference

5 September 2017

13

1 reference

5 September 2017

185-198

1 reference

5 September 2017

3

1 reference

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

5 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Global incidence of oesophageal cancer by histological subtype in 2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Improved long-term survival after esophagectomy for esophageal cancer: influence of epidemiologic shift and neoadjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Clinical evaluation and optimal management of cancer cachexia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Definition and classification of cancer cachexia: an international consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

21 January 2018

Muscle wasting in cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Validation of the Consensus-Definition for Cancer Cachexia and evaluation of a classification model--a study based on data from an international multicentre project (EPCRC-CSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Understanding the mechanisms and treatment options in cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Evidence-based surgical treatment of esophageal cancer: overview of high-quality studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Risk factors for weight loss among patients surviving 5 years after esophageal cancer surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Long-term weight change after oesophageal cancer surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Systematic review of health-related quality of life after esophagectomy for esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Malnutrition, fatigue, frailty, vulnerability, sarcopenia and cachexia: overlap of clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics"

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Clinical nutrition, body composition and oncology: a critical literature review of the synergies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Body composition: why, when and for who?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Diagnostic criteria for the classification of cancer-associated weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Myopenia-a new universal term for muscle wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Therapy insight: Cancer anorexia-cachexia syndrome--when all you can eat is yourself.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

The influence of preoperative weight loss on the postoperative course after esophageal cancer resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Mechanisms of cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Cancer cachexia: mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Cancer-associated cachexia and underlying biological mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Cancer cachexia pathophysiology and translational aspect of herbal medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Systemic inflammation, nutritional status and survival in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

The relationship between nutritional status and the Glasgow prognostic score in patients with cancer of the esophagus and stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Anorexia/cachexia of chronic diseases: a role for the TGF-β family cytokine MIC-1/GDF15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Pathophysiology of cancer cachexia: much more than host-tumour interaction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Increased expression of the ubiquitin-proteasome pathway in murine myotubes by proteolysis-inducing factor (PIF) is associated with activation of the transcription factor NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Interleukin 6 and C-reactive protein in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Soluble interleukin-6 receptor is a serum biomarker for the response of esophageal carcinoma to neoadjuvant chemoradiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Expression of uncoupling proteins-1, -2 and -3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Modulation of adipocyte G-protein expression in cancer cachexia by a lipid-mobilizing factor (LMF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Prognostic value of body mass index for patients undergoing esophagectomy for esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Does morbid obesity worsen outcomes after esophagectomy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

The impact of body mass index on complication and survival in resected oesophageal cancer: a clinical-based cohort and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Autophagic degradation contributes to muscle wasting in cancer cachexia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Weight loss and resting energy expenditure in male patients with newly diagnosed esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Resting energy expenditure and body composition in patients with newly detected cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Appetite and cancer-associated anorexia: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Risk factors for malnutrition after oesophageal and cardia cancer surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Management of Dysphagia in Esophageal Adenocarcinoma Patients Undergoing Neoadjuvant Chemotherapy: Can Invasive Tube Feeding be Avoided?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Nutrition therapy issues in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Sarcopenia is predictive of nosocomial infection in care of the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

The effect of neoadjuvant chemotherapy on physical fitness and survival in patients undergoing oesophagogastric cancer surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Recent developments in esophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Prognostic impact of weight loss in 1-year survivors after transthoracic esophagectomy for cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Postoperative weight loss does not resolve after esophagectomy despite normal serum ghrelin levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Ghrelin level and body weight loss after esophagectomy for esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Reduced plasma ghrelin levels on day 1 after esophagectomy: a new predictor of prolonged systemic inflammatory response syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Long-term health-related quality of life following surgery for oesophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

A systematic review of health-related quality of life instruments in patients with cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

The emerging role of computerized tomography in assessing cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

The energy balance in cancer cachexia revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

A disease-specific enteral nutrition formula improves nutritional status and functional performance in patients with head and neck and esophageal cancer undergoing chemoradiotherapy: results of a randomized, controlled, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Artificial nutritional support in cancer patients after esophagectomy: 11 years of experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Exploiting the critical perioperative period to improve long-term cancer outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

ESPEN Guidelines on Parenteral Nutrition: non-surgical oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

A systematic review on the role of fish oil for the treatment of cachexia in advanced cancer: an EPCRC cachexia guidelines project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Randomized clinical trial of omega-3 fatty acid-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing oesophagogastric cancer surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Esophagectomy in patients with prior percutaneous endoscopic gastrostomy tube placement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

ESPEN Guidelines on Enteral Nutrition: Surgery including organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Medroxyprogesterone acetate in the management of cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Oesophageal cancer and cachexia: the effect of short-term treatment with thalidomide on weight loss and lean body mass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Exercise treatment to counteract protein wasting of chronic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Physical exercise for cancer patients with advanced disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

The effect of progressive resistance training on lean body mass in post-treatment cancer patients - a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Post-oesophagectomy early enteral nutrition via a needle catheter jejunostomy: 8-year experience at a specialist unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Malnutrition after oesophageal cancer surgery in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Glasgow Prognostic Score is a predictor of perioperative and long-term outcome in patients with only surgically treated esophageal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Proteolysis-inducing factor regulates hepatic gene expression via the transcription factors NF-(kappa)B and STAT3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Serum parathyroid hormone-related peptide is associated with systemic inflammation and adverse prognosis in gastroesophageal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Medicine. Lipases in cachexia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care--correlations with food intake, metabolism, exercise capacity, and hormones

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Expression of the proteolysis-inducing factor core peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastro-oesophageal malignancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Autophagic-lysosomal pathway is the main proteolytic system modified in the skeletal muscle of esophageal cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

In vivo and in vitro evidence for the involvement of tumor necrosis factor-alpha in the induction of leptin by lipopolysaccharide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Plasma concentration of total leptin and human lung-cancer-associated cachexia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Circulating leptin and inflammatory response in esophageal cancer, esophageal cancer-related cachexia-anorexia syndrome (CAS) and non-malignant CAS of the alimentary tract

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Changes in body composition secondary to neoadjuvant chemotherapy for advanced esophageal cancer are related to the occurrence of postoperative complications after esophagectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Nutritional Management of Patients With Esophageal and Esophagogastric Junction Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Ghrelin reduction after esophageal substitution and its correlation to postoperative body weight loss in esophageal cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Palliation of Dysphagia of Esophageal Cancer by Endoscopic Lumen Restoration Techniques

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Cancer cachexia and fat-muscle physiology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Evidence based practice guidelines for the nutritional management of cancer cachexia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Surgery in esophageal and gastric cancer patients: what is the role for nutrition support in your daily practice?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Dietician-delivered intensive nutritional support is associated with a decrease in severe postoperative complications after surgery in patients with esophageal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Perioperative arginine-supplemented nutrition in malnourished patients with head and neck cancer improves long-term survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Early enteral nutrition compared with parenteral nutrition for esophageal cancer patients after esophagectomy: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Randomized phase II study of clinical effects of ghrelin after esophagectomy with gastric tube reconstruction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Randomized Phase II Study of the Anti-inflammatory Effect of Ghrelin During the Postoperative Period of Esophagectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Poor tolerability of thalidomide in end-stage oesophageal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.200

Reassessment of the role of enteral tube feedings for patients with esophageal cancer.

31 March 2020

1 reference

12 December 2020

Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia

1 reference

12 December 2020

Effect of weight loss and the inflammatory response on leptin concentrations in gastrointestinal cancer patients.

1 reference

12 December 2020

Cancer anorexia-cachexia syndrome: are neuropeptides the key?

1 reference

12 December 2020

Effects of megestrol acetate in patients with cancer anorexia-cachexia syndrome--a systematic review and meta-analysis.

1 reference

12 December 2020

Clinical determinants of weight loss in patients with esophageal carcinoma during radiotherapy: a prospective longitudinal view

1 reference

12 December 2020

10.1038/NRCLINONC.2015.200

Identifiers

DOI

1 reference

5 September 2017

1 reference

PubMed ID

26573424